The bottom line: you can get a prescription, fill it, and start treatment today
These studies, while promising, cannot fully predict how the peptide will behave in human systems
Combined with biomarkers and clinical history, genetic insights can support a more informed provider conversation about medication selection and expected tolerability
Get evaluated by Celeste Cisneros, FNP-BC full health history, goals review, contraindication screen, lab review
If your insurance covers Wegovy or Zepbound, you get FDA-approved medications at a fraction of the out-of-pocket cost, with full regulatory oversight
PubMed pubmed.ncbi.nlm.nih.gov [87] Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis ScienceDirect [88] GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review ScienceDirect